Vaxart Inc
NASDAQ:VXRT
Vaxart Inc
NASDAQ:VXRT
Price:
0.77
USD
-3.7%
Market Closed
Market Cap:
$184.9m
Balance Sheet
Balance Sheet Decomposition
Vaxart Inc
Vaxart Inc
Balance Sheet Decomposition is not available for
Vaxart Inc
Vaxart Inc
Balance Sheet
Vaxart Inc
Vaxart Inc
Currency: USD
| Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||
| Cash & Cash Equivalents |
2
|
12
|
14
|
127
|
144
|
46
|
35
|
25
|
|
| Cash |
0
|
0
|
0
|
67
|
73
|
15
|
3
|
9
|
|
| Cash Equivalents |
2
|
12
|
14
|
60
|
71
|
31
|
31
|
16
|
|
| Short-Term Investments |
1
|
0
|
0
|
0
|
23
|
50
|
5
|
26
|
|
| Total Receivables |
1
|
2
|
4
|
0
|
0
|
0
|
3
|
12
|
|
| Accounts Receivables |
1
|
0
|
4
|
0
|
0
|
0
|
0
|
12
|
|
| Other Receivables |
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
1
|
1
|
1
|
3
|
4
|
3
|
5
|
|
| Total Current Assets |
4
|
15
|
18
|
129
|
169
|
100
|
46
|
68
|
|
| PP&E Net |
1
|
1
|
2
|
8
|
20
|
41
|
37
|
29
|
|
| PP&E Gross |
1
|
1
|
0
|
8
|
20
|
41
|
37
|
29
|
|
| Accumulated Depreciation |
1
|
2
|
0
|
1
|
1
|
3
|
7
|
11
|
|
| Intangible Assets |
0
|
19
|
17
|
15
|
11
|
5
|
4
|
4
|
|
| Goodwill |
0
|
0
|
0
|
0
|
5
|
5
|
5
|
5
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
16
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
1
|
4
|
1
|
61
|
|
| Other Assets |
0
|
0
|
0
|
0
|
5
|
5
|
5
|
5
|
|
| Total Assets |
5
N/A
|
35
+682%
|
37
+5%
|
153
+312%
|
221
+45%
|
154
-30%
|
92
-40%
|
166
+81%
|
|
| Liabilities | |||||||||
| Accounts Payable |
1
|
1
|
1
|
2
|
4
|
6
|
2
|
7
|
|
| Accrued Liabilities |
2
|
1
|
5
|
6
|
5
|
8
|
8
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
2
|
2
|
3
|
3
|
1
|
0
|
4
|
4
|
|
| Other Current Liabilities |
0
|
3
|
0
|
1
|
1
|
4
|
1
|
66
|
|
| Total Current Liabilities |
5
|
8
|
9
|
12
|
11
|
18
|
14
|
91
|
|
| Long-Term Debt |
39
|
2
|
13
|
12
|
11
|
6
|
3
|
2
|
|
| Other Liabilities |
0
|
15
|
2
|
5
|
12
|
20
|
18
|
15
|
|
| Total Liabilities |
43
N/A
|
24
-44%
|
24
+0%
|
29
+21%
|
34
+15%
|
43
+29%
|
34
-21%
|
107
+216%
|
|
| Equity | |||||||||
| Common Stock |
0
|
1
|
5
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
80
|
98
|
117
|
149
|
219
|
327
|
410
|
477
|
|
| Additional Paid In Capital |
41
|
109
|
125
|
272
|
407
|
438
|
468
|
536
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Equity |
39
N/A
|
11
N/A
|
13
+16%
|
123
+849%
|
188
+52%
|
111
-41%
|
58
-48%
|
59
+2%
|
|
| Total Liabilities & Equity |
5
N/A
|
35
+682%
|
37
+5%
|
153
+312%
|
221
+45%
|
154
-30%
|
92
-40%
|
166
+81%
|
|
| Shares Outstanding | |||||||||
| Common Shares Outstanding |
0
|
7
|
48
|
110
|
126
|
134
|
153
|
228
|
|
Switch to:
Switch to:
See Also
Discover More
